Fulcrum Therapeutics

News

Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.

News

Company launched following $55 million series A funding round.

News

Researchers have developed an AI model, trained on millions of facial images, that can directly predict survival risk in patients with cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.